PHK
AMRX icon

Point72 Hong Kong’s Amneal Pharmaceuticals AMRX Stock Holding History

Point72 Hong Kong’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,823
Closed -$18K – 135
2022
Q3 		$18K Buy
+8,823
New +$24.7K ﹤0.01% 1632
2022
Q2 		– Sell
-5,239
Closed -$22K – 1886
2022
Q1 		$22K Buy
5,239
+2,558
+95% +$11.3K ﹤0.01% 1511
2021
Q4 		$13K Sell
2,681
-337
-11% -$1.68K ﹤0.01% 1605
2021
Q3 		$16K Buy
3,018
+661
+28% +$3.33K ﹤0.01% 1728
2021
Q2 		$12K Sell
2,357
-1,006
-30% -$5.72K ﹤0.01% 1712
2021
Q1 		$23K Buy
+3,363
New +$18.6K ﹤0.01% 1441
2020
Q4 		– Sell
-6,961
Closed -$27K – 1694
2020
Q3 		$27K Buy
+6,961
New +$29.8K ﹤0.01% 809
2020
Q2 		– Sell
-20,975
Closed -$73K – 1129
2020
Q1 		$73K Buy
+20,975
New +$88.8K 0.03% 258
2019
Q3 		– Sell
-7,085
Closed -$51K – 984
2019
Q2 		$51K Sell
7,085
-2,012
-22% -$20.6K 0.01% 632
2019
Q1 		$129K Sell
9,097
-1,891
-17% -$25K 0.05% 291
2018
Q4 		$149K Buy
10,988
+10,770
+4,940% +$194K 0.07% 127
2018
Q3 		$5K Sell
218
-3,150
-94% -$66.3K ﹤0.01% 704
2018
Q2 		$55K Buy
+3,368
New +$59.1K 0.02% 411

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Hong Kong's AMRX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Amneal Pharmaceuticals (AMRX) in Q4 2022, closing a stake of 8,823 shares — an estimated $18K sold.

Point72 Hong Kong first reported a position in AMRX in Q2 2018 and held it in 13 quarters. The position peaked at $149K in Q4 2018. 156 funds tracked by Wall St. Rank hold AMRX as of Q4 2022.

  • Point72 Hong Kong reported no remaining Amneal Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 8,823 Amneal Pharmaceuticals shares in Q4 2022, an estimated $18K.
  • Point72 Hong Kong first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 13 quarters.
  • Point72 Hong Kong's Amneal Pharmaceuticals position peaked at $149K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.